The Mayo Clinic Comprehensive Cancer Center Blog shares news, information, and stories from Mayo Clinic’s cancer experts and patients. Stories featured recently on the blog include:
- New research discovers a new combination of therapy for people with a type of leukemia, leading them to live longer
Study results showed significantly higher survival rates when blinatumomab was added to chemotherapy for people with B-cell acute lymphoblastic leukemia. - Detecting pancreatic cancer through changes in body composition and metabolism
New Mayo Clinic research represents a promising step toward identifying biological signals or biomarkers that may aid in early detection. - Uterine cancer rates are increasing: What can you do to protect yourself?
Kristina Butler, a gynecologic oncologist, explains what you need to know about uterine cancer to stay vigilant and reduce your risk. - Cancer fatigue: A common cancer side effect that is different for everyone
Touré Barksdale and Jenny Bradt, D.P.T., discuss how cancer fatigue affects people differently and how it can be improved.
Is there a topic you would like to read about on the Cancer Center Blog? Would you like to share your story with Cancer Center Blog readers? Let us know in the comments or email the blog editor at cancerblog@mayo.edu.
To ask questions, get answers, and connect with people living with and beyond cancer, join the Cancer Support Group.
How and when is Keytruda used successfully and for which cancer?
@rfherald
Can not answer you question directly. But I searched Mayo Connect and see reference Keytruda in multiple cancer groups.
https://connect.mayoclinic.org/search/?search=Keytruda
What type of cancer are you asking about?
@roch I have cancer of the duodenum.
Thank you for the question!
The current FDA overview for Keytruda is available here: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/125514s161lbl.pdf#page=165. It lists the various cancers Keytruda is approved for.